UBS Group Portfolio holdings
UBS Group is the Swiss bank holding company behind UBS, which was created in 1998 when Union Bank of Switzerland merged with Swiss Bank Corporation; the holding company was listed in New York in 2014. Its business spans wealth management, investment banking, asset management and banking for individuals and companies. Its asset management arm offers stock, bond, currency, hedge fund, real estate, infrastructure and private equity strategies, which can also be combined in multi-asset portfolios. The group's roots go back to the Bank in Winterthur, founded in 1862, and to Swiss Bank Corporation, started by six private bankers in Basel by 1854. The wealth management arm serves high net worth individuals worldwide, and its US business grew out of Paine Webber, the American brokerage UBS merged with in 2000 and renamed UBS Wealth Management USA in 2003. In 2023 UBS took over Credit Suisse in a rescue deal arranged by the Swiss government and central bank.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.15B |
| 2 |
HONA
Honeywell Aerospace
HONA
|
+$611M |
| 3 |
SpaceX
SPCX
|
+$567M |
| 4 |
Apple
AAPL
|
+$511M |
| 5 |
Jabil
JBL
|
+$463M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$1.49B |
| 2 |
Western Digital
WDC
|
+$1.42B |
| 3 |
Lumentum
LITE
|
+$951M |
| 4 |
Intel
INTC
|
+$785M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$749M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 41.93% |
| 2 | Technology | 18.61% |
| 3 | Financials | 7.85% |
| 4 | Industrials | 6.96% |
| 5 | Healthcare | 5.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4601
Chagee Holdings Ltd
CHA
$2.37B
| $3.2M | ﹤0.01% |
265,846
-346,198
| -57% | -$3.77M |
2025 Q2
4 quarters
|
|
4602
PUT
James Hardie Industries
JHX
$16.2B
| $3.19M | ﹤0.01% |
121,800
-24,800
| -17% | -$545K |
2025 Q3
3 quarters
|
|
4603
Under Armour Class C
UA
$2.19B
| $3.19M | ﹤0.01% |
512,355
-1,727,586
| -77% | -$10M |
2016 Q2
40 quarters
|
|
4604
Invesco S&P 500 Equal Weight Financials ETF
RSPF
$329M
| $3.18M | ﹤0.01% |
41,067
-221
| -0.5% | -$16.7K |
2014 Q4
46 quarters
|
|
4605
PUT
Credit Acceptance
CACC
$5.37B
| $3.18M | ﹤0.01% |
5,000
| – | – |
2025 Q3
3 quarters
|
|
4606
CALL
Kratos Defense & Security Solutions
KTOS
$6.61B
| $3.18M | ﹤0.01% |
63,738
+21,570
| +51% | +$1.3M |
2026 Q1
1 quarter
|
|
4607
Saba Capital Income & Opportunities Fund
BRW
$309M
| $3.17M | ﹤0.01% |
482,986
+7,096
| +1% | +$47.8K |
2014 Q4
46 quarters
|
|
4608
PUT
State Street SPDR S&P Biotech ETF
XBI
$10.4B
| $3.16M | ﹤0.01% |
20,000
-430,200
| -96% | -$58.2M |
2016 Q3
39 quarters
|
|
4609
Gran Tierra Energy
GTE
$333M
| $3.16M | ﹤0.01% |
505,894
+82,950
| +20% | +$678K |
2014 Q4
46 quarters
|
|
4610
Savara
SVRA
$992M
| $3.16M | ﹤0.01% |
513,026
-83,689
| -14% | -$449K |
2016 Q2
40 quarters
|
|
4611
Liberty Capital Corp Series C GCI Group Common Stock
GLIBK
$1.06B
| $3.16M | ﹤0.01% |
146,577
-3,702,858
| -96% | -$104M |
2025 Q3
3 quarters
|
|
4612
Ambiq Micro
AMBQ
$933M
| $3.16M | ﹤0.01% |
35,786
-130,051
| -78% | -$7.71M |
2025 Q3
3 quarters
|
|
4613
Davis Select International ETF
DINT
$265M
| $3.15M | ﹤0.01% |
110,663
+9,321
| +9% | +$268K |
2019 Q2
28 quarters
|
|
4614
Crescent Biopharma
CBIO
$503M
| $3.15M | ﹤0.01% |
175,182
+92,476
| +112% | +$1.81M |
2023 Q4
10 quarters
|
|
4615
CALL
ASP Isotopes
ASPI
$319M
| $3.15M | ﹤0.01% |
506,900
+356,900
| +238% | +$2.1M |
2026 Q1
1 quarter
|
|
4616
Perella Weinberg Partners
PWP
$1.11B
| $3.15M | ﹤0.01% |
197,295
-30,993
| -14% | -$567K |
2021 Q4
18 quarters
|
|
4617
Marqeta
MQ
$1.93B
| $3.15M | ﹤0.01% |
193,684
-217,272
| -53% | -$3.53M |
2021 Q2
20 quarters
|
|
4618
PUT
Axon Enterprise
AXON
$25.4B
| $3.14M | ﹤0.01% |
5,600
-13,500
| -71% | -$5.65M |
2023 Q3
11 quarters
|
|
4619
Genco Shipping & Trading
GNK
$1.13B
| $3.12M | ﹤0.01% |
126,102
-53
| -0% | -$1.28K |
2017 Q1
37 quarters
|
|
4620
PUT
Xylem
XYL
$22.4B
| $3.12M | ﹤0.01% |
+26,400
| New | +$3.05M |
2026 Q2
0 quarters
|
|
4621
CALL
McCormick & Company Non-Voting
MKC
$13B
| $3.12M | ﹤0.01% |
+61,800
| New | +$3.03M |
2026 Q2
0 quarters
|
|
4622
First Trust Mid Cap Value AlphaDEX Fund
FNK
$238M
| $3.11M | ﹤0.01% |
50,793
-345
| -0.7% | -$20.5K |
2014 Q4
46 quarters
|
|
4623
American Battery Technology Co
ABAT
$190M
| $3.11M | ﹤0.01% |
1,099,869
-653,387
| -37% | -$2.09M |
2024 Q3
7 quarters
|
|
4624
Invesco Russell 2000 Dynamic Multifactor ETF
OMFS
$263M
| $3.11M | ﹤0.01% |
58,343
-2,706
| -4% | -$136K |
2021 Q3
19 quarters
|
|
4625
ProShares UltraPro S&P 500
UPRO
$4.73B
| $3.1M | ﹤0.01% |
21,886
-12,562
| -36% | -$1.66M |
2023 Q1
13 quarters
|
|
Similar funds
UBS Group's Q2 2026 Portfolio in Review
As of Q2 2026, UBS Group held 11,684 positions worth $786B, up 18% from $666B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS Group's Q2 2026 filing shows 1,281 new, 4,217 increased, 4,362 reduced and 1,275 closed positions. Its largest new stake was Honeywell Aerospace: 2,768,136 shares worth $612M. The largest sale was ExxonMobil, an estimated $1.49B.
By sector, the portfolio is most concentrated in Miscellaneous at 42% of assets, up from 39% a quarter earlier, followed by Technology and Financials.
- UBS Group's largest Q2 2026 buy was Honeywell Aerospace: 2,768,136 shares worth $612M.
- UBS Group added most to Microsoft in Q2 2026, an estimated $1.15B increase.
- UBS Group's biggest Q2 2026 reduction was ExxonMobil, cutting an estimated $1.49B.
- UBS Group fully exited Hologic in Q2 2026, selling an estimated $385M.
- UBS Group's ten largest holdings make up 13% of its $786B portfolio in Q2 2026.
- UBS Group opened 1,281 new positions and closed 1,275 in Q2 2026.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $786B.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.